Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2137 to 2148 of 2167 entries
Sorted by: Best Match Show Resources per page
Impact of health literacy in patients with cardiovascular diseases: A systematic review and meta-analysis.

Patient education and counseling

Kanejima Y, Shimogai T, Kitamura M, Ishihara K, Izawa KP.
PMID: 34862114
Patient Educ Couns. 2021 Nov 27; doi: 10.1016/j.pec.2021.11.021. Epub 2021 Nov 27.

OBJECTIVE: To clarify the impacts of health literacy on mortality, readmission, and quality of life (QOL) in the secondary or tertiary prevention of cardiovascular diseases (CVD) through a meta-analysis.METHODS: Six electronic databases were searched on June 11, 2020. Observational...

Cite
Kanejima Y, Shimogai T, Kitamura M, et al. Impact of health literacy in patients with cardiovascular diseases: A systematic review and meta-analysis. Patient Educ Couns. 2021;doi: 10.1016/j.pec.2021.11.021.
Kanejima, Y., Shimogai, T., Kitamura, M., Ishihara, K., & Izawa, K. P. (2021). Impact of health literacy in patients with cardiovascular diseases: A systematic review and meta-analysis. Patient education and counseling, . https://doi.org/10.1016/j.pec.2021.11.021
Kanejima, Yuji, et al. "Impact of health literacy in patients with cardiovascular diseases: A systematic review and meta-analysis." Patient education and counseling vol. (2021). doi: https://doi.org/10.1016/j.pec.2021.11.021
Kanejima Y, Shimogai T, Kitamura M, Ishihara K, Izawa KP. Impact of health literacy in patients with cardiovascular diseases: A systematic review and meta-analysis. Patient Educ Couns. 2021 Nov 27; doi: 10.1016/j.pec.2021.11.021. Epub 2021 Nov 27. PMID: 34862114.
Copy Download .nbib Format: NLM
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs.

Drug metabolism and pharmacokinetics

Suzuki Y, Ishihara H.
PMID: 34757287
Drug Metab Pharmacokinet. 2021 Oct 10;41:100424. doi: 10.1016/j.dmpk.2021.100424. Epub 2021 Oct 10.

Nucleic acid therapeutics are developing into precise medicines that can manipulate specific genes. However, the development of safe and effective delivery system for the target cells has remained a challenge. Lipid nanoparticles (LNPs) have provided a revolutionary delivery system...

Cite
Suzuki Y, Ishihara H. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metab Pharmacokinet. 2021;41:100424doi: 10.1016/j.dmpk.2021.100424.
Suzuki, Y., & Ishihara, H. (2021). Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug metabolism and pharmacokinetics, 41100424. https://doi.org/10.1016/j.dmpk.2021.100424
Suzuki, Yuta, and Ishihara, Hiroshi. "Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs." Drug metabolism and pharmacokinetics vol. 41 (2021): 100424. doi: https://doi.org/10.1016/j.dmpk.2021.100424
Suzuki Y, Ishihara H. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metab Pharmacokinet. 2021 Oct 10;41:100424. doi: 10.1016/j.dmpk.2021.100424. Epub 2021 Oct 10. PMID: 34757287; PMCID: PMC8502116.
Copy Download .nbib Format: NLM
A chalcone derivative suppresses TSLP induction in mice and human keratinocytes through binding to BET family proteins.

Biochemical pharmacology

Segawa R, Takeda H, Yokoyama T, Ishida M, Miyata C, Saito T, Ishihara R, Nakagita T, Sasano Y, Kanoh N, Iwabuchi Y, Mizuguchi M, Hiratsuka M, Hirasawa N.
PMID: 34757034
Biochem Pharmacol. 2021 Dec;194:114819. doi: 10.1016/j.bcp.2021.114819. Epub 2021 Oct 30.

Although treatments for allergic diseases have improved, side effects and treatment resistance remain as challenges. New therapeutic drugs for allergic diseases are urgently required. Thymic stromal lymphopoietin (TSLP) is a cytokine target for prevention and treatment of allergic diseases....

Cite
Segawa R, Takeda H, Yokoyama T, et al. A chalcone derivative suppresses TSLP induction in mice and human keratinocytes through binding to BET family proteins. Biochem Pharmacol. 2021;194:114819doi: 10.1016/j.bcp.2021.114819.
Segawa, R., Takeda, H., Yokoyama, T., Ishida, M., Miyata, C., Saito, T., Ishihara, R., Nakagita, T., Sasano, Y., Kanoh, N., Iwabuchi, Y., Mizuguchi, M., Hiratsuka, M., & Hirasawa, N. (2021). A chalcone derivative suppresses TSLP induction in mice and human keratinocytes through binding to BET family proteins. Biochemical pharmacology, 194114819. https://doi.org/10.1016/j.bcp.2021.114819
Segawa, Ryosuke, et al. "A chalcone derivative suppresses TSLP induction in mice and human keratinocytes through binding to BET family proteins." Biochemical pharmacology vol. 194 (2021): 114819. doi: https://doi.org/10.1016/j.bcp.2021.114819
Segawa R, Takeda H, Yokoyama T, Ishida M, Miyata C, Saito T, Ishihara R, Nakagita T, Sasano Y, Kanoh N, Iwabuchi Y, Mizuguchi M, Hiratsuka M, Hirasawa N. A chalcone derivative suppresses TSLP induction in mice and human keratinocytes through binding to BET family proteins. Biochem Pharmacol. 2021 Dec;194:114819. doi: 10.1016/j.bcp.2021.114819. Epub 2021 Oct 30. PMID: 34757034.
Copy Download .nbib Format: NLM
Effect of Specimen Thickness and Stress Intensity Factor Range on Plasticity-Induced Fatigue Crack Closure in A7075-T6 Alloy.

Materials (Basel, Switzerland)

Masuda K, Ishihara S, Oguma N.
PMID: 33572686
Materials (Basel). 2021 Jan 31;14(3). doi: 10.3390/ma14030664.

Fatigue crack growth experiments are performed using A7075-T6 compact tension (CT) specimens with various thicknesses

Cite
Masuda K, Ishihara S, Oguma N. Effect of Specimen Thickness and Stress Intensity Factor Range on Plasticity-Induced Fatigue Crack Closure in A7075-T6 Alloy. Materials (Basel). 2021;14(3)doi: 10.3390/ma14030664.
Masuda, K., Ishihara, S., & Oguma, N. (2021). Effect of Specimen Thickness and Stress Intensity Factor Range on Plasticity-Induced Fatigue Crack Closure in A7075-T6 Alloy. Materials (Basel, Switzerland), 14(3), . https://doi.org/10.3390/ma14030664
Masuda, Kenichi, et al. "Effect of Specimen Thickness and Stress Intensity Factor Range on Plasticity-Induced Fatigue Crack Closure in A7075-T6 Alloy." Materials (Basel, Switzerland) vol. 14,3 (2021). doi: https://doi.org/10.3390/ma14030664
Masuda K, Ishihara S, Oguma N. Effect of Specimen Thickness and Stress Intensity Factor Range on Plasticity-Induced Fatigue Crack Closure in A7075-T6 Alloy. Materials (Basel). 2021 Jan 31;14(3). doi: 10.3390/ma14030664. PMID: 33572686; PMCID: PMC7866977.
Copy Download .nbib Format: NLM
Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture.

ACS applied bio materials

Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R.
PMID: 35016379
ACS Appl Bio Mater. 2018 Aug 20;1(2):356-366. doi: 10.1021/acsabm.8b00096. Epub 2018 Jul 20.

There is considerable interest in the cryopreservation in 3D cell culture, as structurally preserving intact cells and tissues is critical in utilizing these systems to promote cell differentiation and tissue organization. Temperature-responsive physical gels and zwitterionic polymers are useful...

Cite
Nagao M, Sengupta J, Diaz-Dussan D, et al. Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture. ACS Appl Bio Mater. 2018;1(2):356-366doi: 10.1021/acsabm.8b00096.
Nagao, M., Sengupta, J., Diaz-Dussan, D., Adam, M., Wu, M., Acker, J., Ben, R., Ishihara, K., Zeng, H., Miura, Y., & Narain, R. (2018). Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture. ACS applied bio materials, 1(2), 356-366. https://doi.org/10.1021/acsabm.8b00096
Nagao, Masanori, et al. "Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture." ACS applied bio materials vol. 1,2 (2018): 356-366. doi: https://doi.org/10.1021/acsabm.8b00096
Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R. Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture. ACS Appl Bio Mater. 2018 Aug 20;1(2):356-366. doi: 10.1021/acsabm.8b00096. Epub 2018 Jul 20. PMID: 35016379.
Copy Download .nbib Format: NLM
Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome.

Leukemia

Yoshino S, Tanaka M, Sunami Y, Takahara T, Yamazaki Y, Homme M, Niibori-Nambu A, Osato M, Minami T, Ishihara K, Nakamura T.
PMID: 34381180
Leukemia. 2021 Aug 11; doi: 10.1038/s41375-021-01384-1. Epub 2021 Aug 11.

No abstract available.

Cite
Yoshino S, Tanaka M, Sunami Y, et al. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome. Leukemia. 2021;doi: 10.1038/s41375-021-01384-1.
Yoshino, S., Tanaka, M., Sunami, Y., Takahara, T., Yamazaki, Y., Homme, M., Niibori-Nambu, A., Osato, M., Minami, T., Ishihara, K., & Nakamura, T. (2021). Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome. Leukemia, . https://doi.org/10.1038/s41375-021-01384-1
Yoshino, Seiko, et al. "Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome." Leukemia vol. (2021). doi: https://doi.org/10.1038/s41375-021-01384-1
Yoshino S, Tanaka M, Sunami Y, Takahara T, Yamazaki Y, Homme M, Niibori-Nambu A, Osato M, Minami T, Ishihara K, Nakamura T. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome. Leukemia. 2021 Aug 11; doi: 10.1038/s41375-021-01384-1. Epub 2021 Aug 11. PMID: 34381180.
Copy Download .nbib Format: NLM
γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis.

Cancer gene therapy

Taniguchi K, Kageyama S, Moyama C, Ando S, Ii H, Ashihara E, Horinaka M, Sakai T, Kubota S, Kawauchi A, Nakata S.
PMID: 33402732
Cancer Gene Ther. 2022 Jan;29(1):37-48. doi: 10.1038/s41417-020-00287-0. Epub 2021 Jan 05.

Metabolic reprogramming leading to aerobic glycolysis, termed the "Warburg effect," is a critical property of cancer cells. However, the precise mechanisms underlying this phenomenon are not fully understood. A growing body of evidence indicates that γ-glutamylcyclotransferase (GGCT), an enzyme...

Cite
Taniguchi K, Kageyama S, Moyama C, et al. γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis. Cancer Gene Ther. 2021;29(1):37-48doi: 10.1038/s41417-020-00287-0.
Taniguchi, K., Kageyama, S., Moyama, C., Ando, S., Ii, H., Ashihara, E., Horinaka, M., Sakai, T., Kubota, S., Kawauchi, A., & Nakata, S. (2022). γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis. Cancer gene therapy, 29(1), 37-48. https://doi.org/10.1038/s41417-020-00287-0
Taniguchi, Keiko, et al. "γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis." Cancer gene therapy vol. 29,1 (2022): 37-48. doi: https://doi.org/10.1038/s41417-020-00287-0
Taniguchi K, Kageyama S, Moyama C, Ando S, Ii H, Ashihara E, Horinaka M, Sakai T, Kubota S, Kawauchi A, Nakata S. γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis. Cancer Gene Ther. 2022 Jan;29(1):37-48. doi: 10.1038/s41417-020-00287-0. Epub 2021 Jan 05. PMID: 33402732.
Copy Download .nbib Format: NLM
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs.

Drug metabolism and pharmacokinetics

Suzuki Y, Ishihara H.
PMID: 34757287
Drug Metab Pharmacokinet. 2021 Dec;41:100424. doi: 10.1016/j.dmpk.2021.100424. Epub 2021 Oct 10.

Nucleic acid therapeutics are developing into precise medicines that can manipulate specific genes. However, the development of safe and effective delivery system for the target cells has remained a challenge. Lipid nanoparticles (LNPs) have provided a revolutionary delivery system...

Cite
Suzuki Y, Ishihara H. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metab Pharmacokinet. 2021;41:100424doi: 10.1016/j.dmpk.2021.100424.
Suzuki, Y., & Ishihara, H. (2021). Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug metabolism and pharmacokinetics, 41100424. https://doi.org/10.1016/j.dmpk.2021.100424
Suzuki, Yuta, and Ishihara, Hiroshi. "Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs." Drug metabolism and pharmacokinetics vol. 41 (2021): 100424. doi: https://doi.org/10.1016/j.dmpk.2021.100424
Suzuki Y, Ishihara H. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metab Pharmacokinet. 2021 Dec;41:100424. doi: 10.1016/j.dmpk.2021.100424. Epub 2021 Oct 10. PMID: 34757287; PMCID: PMC8502116.
Copy Download .nbib Format: NLM
Clinical significance of CD8.

Molecular and clinical oncology

Harada Y, Kazama S, Morikawa T, Sonoda H, Ishi H, Emoto S, Murono K, Kaneko M, Sasaki K, Shuno Y, Nishikawa T, Tanaka T, Kawai K, Hata K, Nozawa H, Ushiku T, Tahara H, Ishihara S.
PMID: 33767856
Mol Clin Oncol. 2021 May;14(5):87. doi: 10.3892/mco.2021.2249. Epub 2021 Mar 05.

Preoperative chemoradiotherapy (CRT) for rectal cancer contributes to tumor down-staging and decreases locoregional recurrence. However, each patient shows a significantly different response to CRT. Therefore, the identification of predictive factors to CRT response would be beneficial to avoid unnecessary...

Cite
Harada Y, Kazama S, Morikawa T, et al. Clinical significance of CD8. Mol Clin Oncol. 2021;14(5):87doi: 10.3892/mco.2021.2249.
Harada, Y., Kazama, S., Morikawa, T., Sonoda, H., Ishi, H., Emoto, S., Murono, K., Kaneko, M., Sasaki, K., Shuno, Y., Nishikawa, T., Tanaka, T., Kawai, K., Hata, K., Nozawa, H., Ushiku, T., Tahara, H., & Ishihara, S. (2021). Clinical significance of CD8. Molecular and clinical oncology, 14(5), 87. https://doi.org/10.3892/mco.2021.2249
Harada, Yuzo, et al. "Clinical significance of CD8." Molecular and clinical oncology vol. 14,5 (2021): 87. doi: https://doi.org/10.3892/mco.2021.2249
Harada Y, Kazama S, Morikawa T, Sonoda H, Ishi H, Emoto S, Murono K, Kaneko M, Sasaki K, Shuno Y, Nishikawa T, Tanaka T, Kawai K, Hata K, Nozawa H, Ushiku T, Tahara H, Ishihara S. Clinical significance of CD8. Mol Clin Oncol. 2021 May;14(5):87. doi: 10.3892/mco.2021.2249. Epub 2021 Mar 05. PMID: 33767856; PMCID: PMC7976375.
Copy Download .nbib Format: NLM
Genetic mapping identifies a rice naringenin O-glucosyltransferase that influences insect resistance.

The Plant journal : for cell and molecular biology

Yang Z, Li N, Kitano T, Li P, Spindel JE, Wang L, Bai G, Xiao Y, McCouch SR, Ishihara A, Zhang J, Yang X, Chen Z, Wei J, Ge H, Jander G, Yan J.
PMID: 33745166
Plant J. 2021 Jun;106(5):1401-1413. doi: 10.1111/tpj.15244. Epub 2021 Apr 17.

Naringenin, the biochemical precursor for predominant flavonoids in grasses, provides protection against UV damage, pathogen infection and insect feeding. To identify previously unknown loci influencing naringenin accumulation in rice (Oryza sativa), recombinant inbred lines derived from the Nipponbare and...

Cite
Yang Z, Li N, Kitano T, et al. Genetic mapping identifies a rice naringenin O-glucosyltransferase that influences insect resistance. Plant J. 2021;106(5):1401-1413doi: 10.1111/tpj.15244.
Yang, Z., Li, N., Kitano, T., Li, P., Spindel, J. E., Wang, L., Bai, G., Xiao, Y., McCouch, S. R., Ishihara, A., Zhang, J., Yang, X., Chen, Z., Wei, J., Ge, H., Jander, G., & Yan, J. (2021). Genetic mapping identifies a rice naringenin O-glucosyltransferase that influences insect resistance. The Plant journal : for cell and molecular biology, 106(5), 1401-1413. https://doi.org/10.1111/tpj.15244
Yang, Zhongyan, et al. "Genetic mapping identifies a rice naringenin O-glucosyltransferase that influences insect resistance." The Plant journal : for cell and molecular biology vol. 106,5 (2021): 1401-1413. doi: https://doi.org/10.1111/tpj.15244
Yang Z, Li N, Kitano T, Li P, Spindel JE, Wang L, Bai G, Xiao Y, McCouch SR, Ishihara A, Zhang J, Yang X, Chen Z, Wei J, Ge H, Jander G, Yan J. Genetic mapping identifies a rice naringenin O-glucosyltransferase that influences insect resistance. Plant J. 2021 Jun;106(5):1401-1413. doi: 10.1111/tpj.15244. Epub 2021 Apr 17. PMID: 33745166.
Copy Download .nbib Format: NLM
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga Y, Courtney K, Cantarel B, Wakeland EK, Fu YX, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J.
PMID: 34551906
Clin Cancer Res. 2021 Dec 15;27(24):6716-6725. doi: 10.1158/1078-0432.CCR-21-2083. Epub 2021 Sep 22.

PURPOSE: This phase II clinical trial evaluated whether the addition of stereotactic ablative radiotherapy (SAbR), which may promote tumor antigen presentation, improves the overall response rate (ORR) to high-dose IL2 (HD IL2) in metastatic renal cell carcinoma (mRCC).PATIENTS AND...

Cite
Hannan R, Mohamad O, Diaz de Leon A, et al. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2021;27(24):6716-6725doi: 10.1158/1078-0432.CCR-21-2083.
Hannan, R., Mohamad, O., Diaz de Leon, A., Manna, S., Pop, L. M., Zhang, Z., Mannala, S., Christie, A., Christley, S., Monson, N., Ishihara, D., Hsu, E. J., Ahn, C., Kapur, P., Chen, M., Arriaga, Y., Courtney, K., Cantarel, B., Wakeland, E. K., Fu, Y. X., Pedrosa, I., Cowell, L., Wang, T., Margulis, V., Choy, H., Timmerman, R. D., & Brugarolas, J. (2021). Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(24), 6716-6725. https://doi.org/10.1158/1078-0432.CCR-21-2083
Hannan, Raquibul, et al. "Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,24 (2021): 6716-6725. doi: https://doi.org/10.1158/1078-0432.CCR-21-2083
Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga Y, Courtney K, Cantarel B, Wakeland EK, Fu YX, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2021 Dec 15;27(24):6716-6725. doi: 10.1158/1078-0432.CCR-21-2083. Epub 2021 Sep 22. PMID: 34551906.
Copy Download .nbib Format: NLM
Separation from a bonded partner alters neural response to inflammatory pain in monogamous rodents.

Behavioural brain research

Okuda T, Osako Y, Hidaka C, Nishihara M, Young LJ, Mitsui S, Yuri K.
PMID: 34748865
Behav Brain Res. 2022 Feb 10;418:113650. doi: 10.1016/j.bbr.2021.113650. Epub 2021 Nov 05.

Pain experience is known to be modified by social factors, but the brain mechanisms remain unspecified. We recently established an animal model of social stress-induced hyperalgesia (SSIH) using a socially monogamous rodent, the prairie vole, in which males separated...

Cite
Okuda T, Osako Y, Hidaka C, et al. Separation from a bonded partner alters neural response to inflammatory pain in monogamous rodents. Behav Brain Res. 2021;418:113650doi: 10.1016/j.bbr.2021.113650.
Okuda, T., Osako, Y., Hidaka, C., Nishihara, M., Young, L. J., Mitsui, S., & Yuri, K. (2022). Separation from a bonded partner alters neural response to inflammatory pain in monogamous rodents. Behavioural brain research, 418113650. https://doi.org/10.1016/j.bbr.2021.113650
Okuda, Takahiro, et al. "Separation from a bonded partner alters neural response to inflammatory pain in monogamous rodents." Behavioural brain research vol. 418 (2022): 113650. doi: https://doi.org/10.1016/j.bbr.2021.113650
Okuda T, Osako Y, Hidaka C, Nishihara M, Young LJ, Mitsui S, Yuri K. Separation from a bonded partner alters neural response to inflammatory pain in monogamous rodents. Behav Brain Res. 2022 Feb 10;418:113650. doi: 10.1016/j.bbr.2021.113650. Epub 2021 Nov 05. PMID: 34748865.
Copy Download .nbib Format: NLM
Showing 2137 to 2148 of 2167 entries